Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COA8 gene.
Features include always present findings: Cavitating leukodystrophy and Decreased activity of mitochondrial complex IV; and very common findings: Loss of previously acquired skills (developmental regression) and Spastic tetraparesis. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Delayed speech and language development, Loss of previously acquired skills (developmental regression), Seizure |
COA8 encodes cytochrome c oxidase assembly factor 8 (206 aa). Required for cytochrome c complex (COX) IV assembly and function Protects COX assembly from oxidation-induced degradation, COX being the terminal component of the mitochondrial respiratory chain Highest expression in Testis (59.7 TPM) and Muscle Skeletal (28.6 TPM).
Mitochondrial complex IV deficiency, nuclear type 17 is associated with mutations in the COA8 gene on chromosome 14.
COA8 is classified as a druggable target with score 0.0.
Genetic testing for COA8 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 2 very common features, 5 common features.
No clinical trials have been registered for mitochondrial complex IV deficiency, nuclear type 17.
2 publications have been identified in PubMed for mitochondrial complex IV deficiency, nuclear type 17. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Campos-Ribeiro MA (2026). [PMID: 41420107](https://pubmed.ncbi.nlm.nih.gov/41420107/). *EMBO Mol Med*. [Basic Science / Preclinical]
Tavasoli A (2024). [PMID: 38846886](https://pubmed.ncbi.nlm.nih.gov/38846886/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lab test results | 1 | Decreased activity of mitochondrial complex IV |
Muscles | 1 | Cytochrome C oxidase-negative muscle fibers |